[1]
“COST-EFFECTIVENESS ANALYSIS OF AVELUMAB TREATMENT FOR PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA”, Вопр. онкол., vol. 66, no. 2, pp. 109–119, Feb. 2020, doi: 10.37469/0507-3758-2020-66-2-109-119.